nutriventia.com | sales@nutriventia.comScience backed, tech driven,clean ingredients that‘ ’
Nutriventia E.D.G.E.Enhanced Delivery for Greater EicacyAt the heart of every product is Our proprietary delivery technology platformsOur Breakthrough products built for you5 4ModifiedReleaseAll-night sleepAll-day focusAll-day immunityglowSkin healthPeak musculoskeletal healthactive5Sustained-release melatonin that supports a natural 8-hour sleep cycleDirectly compressible Vitamin C for 24 hour immune support and reinforced wellness.New LaunchWater dispersible turmeric extract with clinically proven absorption eiciency Turmeric extract for beauty from within, eective at a low 250mg dose.All-day calmRoot only, sustained release ashawagandhaSustained-release caeine deliv-ering up to 12 hours of smooth mental energy and focus without the "crash"
3PKSTUDIES3CLINICAL STUDIESJOINT, DOMS, OA1META-ANALYSIS ANDSYSTEMATIC REVIEW3 human pharmacokinetic trials confirming in-study bio-equivalence of 250mg TurmXTRA™ with 1575mg Turmeric Extract (95% curcuminoids)2 clinical trials in healthy human subjects have proven the efficacy of TurmXTRA™ in improving joint comfort and providing with muscle soreness relief 1 clinical trial in subjects with osteoarthritis has established clinical efficacy of TurmXTRA™ in improving joint mobility and comfort while reducing inflammatory biomarkersThe global joint health supplements market is significantly growing, driven by an aging population and increased physical activity. Turmeric is one of the fastest growing active in the segment, favored for its natural anti-inflammatory benefits. Consumers today increasingly seek natural, low-dose, and effective solutions available in convenient consumption formats for ease and compliance.Peak musculoskeletal healthHigher consumer complianceA low one-a-day dose provides higher consumer compliance.All-naturalNo use of synthetic excipients and surfactants.activeLearn more >APPLICATIONSGummiesHardCapsulesEffervescent TabletsStick PacksReady-To-DrinkMARKET INSIGHTSMarket Value$7 billion7-8%CAGR (by 2030) Joint healthWater dispersible turmeric extract with clinically proven absorption efficiency at a low dose of 250 mg*Any of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.Source: NBJ Condition Specific Report 2023, CRN Consumer Survey Report 2024, Grandview Reserch Report 2025.5
*A complete clinical package3 PHARMACOKINETIC STUDYSTUDY 1 AND STUDY 2One 250 mg dose of TurmXTRA™ is clinically substantiated to show equivalenceto three 500 mg doses of standard 95% turmeric extract. Two independent human PK studies demonstrated consistent results, confirming the reliability of curcuminoid absorption from TurmXTRA™.Pharmacokinetic study 1Source: Thanawala S, Shah R, Alluri KV, Somepalli V, Vaze S, Upadhyay V. Comparative bioavailability of curcuminoidsfrom a water-dispersible high curcuminoid turmeric extract against a generic turmeric extract: a randomized, cross-over,comparative, pharmacokinetic study. J Pharm Pharmacol. 2021 Apr 27;73(6):816-823. doi: 10.1093/jpp/rgab028.PMID: 33755149.Time (h)Mean plasma concentration of totalcurcuminoids (ng/mL)004 8 121020 24203040506070809016TurmXTRA™ Std 95%TETurmXTRA™ Time (h)Mean plasma concentration of totalcurcuminoids (ng/mL)004 8 121020 24203040506016Std 95%TEPharmacokinetic study 2STUDY 3One 250 mg dose of TurmXTRA™ is clinically substantiated to show comparable kinetics to three 500 mg doses of a well known branded ingredient containing turmeric and piperine taken at three different time intervals. Source: Thanawala S, Shah R, Doyle L, Upadhyay V. Comparative pharmacokinetics of curcuminoids from waterdispersible turmeric extract against a curcuminoids-piperine combination : An open label, randomized, balanced,2-Treatment, 2-Sequence, 2-Period Crossover Study. Alt Ther. 2024 Apr; 30 (4) : 18-23Pharmacokinetic study 3Mean plasma concentration of totalcurcuminoids (ng/mL)004 6 81020 2420304050607016TurmXTRA™ Branded 95% TE+5mg piperineTime (h)Any of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.
TurmXTRA™ PlaceboSource: Thanawala S, Shah R, Karlapudi V, Desomayanandam P, Bhuvanendran A. Efficacy and Safety of TurmXTRA® in Delayed Onset MuscleSoreness in Healthy, Recreationally Active Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial. Evid Based Complement AlternatMed. 2022 Aug 5;2022:9110414. doi: 10.1155/2022/9110414. PMID: 35966736; PMCID: PMC9374544.STUDY 5 - DELAYED ONSET MUSCLE SORENESS DOMS STUDYOur randomized, double-blind, placebo-controlled trial on 30 healthy and recreationally active subjects showed the efficacy of TurmXTRA™ in reducing muscle soreness and increasing overall well-being.Change in Recovery Timecompared to placeboChange in Muscle Soreness Recovery as compared to placeboHigher levels of recovery96 hrs post-workout1.5x improvementTime (hr)Percentage RecoveryFaster recoveryIn H&M - Fatigue Scale4x fasterChange in LDH levelscompared to placeboBetter Recovery72 hrs post-workout~9x improvementLDH levelsChange in time in80-meter fast-paced walkMore agility~2x improvementJoint comfortimprovement19%Mobilityimprovement2xOur randomized, double-blind placebo-controlled study on 96 healthy volunteers showed the efficacy of TurmXTRA™ on joint health with significant results.Time (s)Change in pain (VAS) after80-meter fast-paced walkMore comfort~3x improvementVASChange in time in9-stair climbMore agility~1.5x improvementTime (s)TurmXTRA™ PlaceboSource: Thanawala S, Shah R, Alluri KV, Somepalli V, Vaze S, Upadhyay V. Comparative bioavailability of curcuminoids from a water-dispersiblehigh curcuminoid turmeric extract against a generic turmeric extract: a randomized, cross-over, comparative, pharmacokinetic study. J PharmPharmacol. 2021 Apr 27;73(6):816-823. doi: 10.1093/jpp/rgab028. PMID: 33755149.Journal of Pharmacy and Pharmacology, Oxford University PressSTUDY 4 - JOINT HEALTH STUDYAny of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.
2.4x improvementVisual analog scale (100 mm)HEALTH BENEFITSJointhealthHealthyagingBrainhealthImmunehealthLiverhealthLICENSES & CERTIFICATIONSScan to visit websitefor more informationOur randomized, double-blind, placebo controlled, parallel group 90-day study on 139 subjects with mild to moderate knee osteoarthritis proved the efficacy and safety of TurmXTRA™ in significantly reducing pain and improving comfort & knee function.STUDY 6 - OSTEOARTHRITIS STUDYReduced Pain (KOOS) Better Knee FunctionNearly 4x improvement 2.3x improvementTurmXTRA™ PlaceboChange in pain (VAS) ascompared to placeboBetter Comfort (VAS)Knee Injury and Osteoarthritis Outcome scoreChange in pain (KOOS)as compared to placeboChange in knee related quality oflife as compared to placeboKOOS – Pain scoreVAS – Pain scoreEase in knee mobilityThanawala S, Shah R, Alluri K V, Bhupathiraju K, Prasad N, Agarwal N.Efficacy and Safety of a Novel Low-Dose Water-Dispersible Turmeric Extract in the Management of Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. J Pain Res 2025 Jan 25 ; 18 : 411 – 427.TurmXTRA™ is a trademark of Nutriventia Pvt. Ltd. © 2025 nutriventia.com | sales@nutriventia.comAny of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.Please reach out to our Sales Team for information on product availability in your region
3CLINICAL STUDIESJOINT, DOMS, OATurmXTRATM is a standardized turmeric extract providing 150 mg of curcuminoids in a precise 250 mg serving with a potent concentration. Its innovative formulation enhances absorption and effectiveness at a lower dosage compared to traditional turmeric extracts. Produced without any artificial additives or synthetic carriers, TurmXTRATM meets consumer demand for authenticity and simplicity. Designed for versatility and purity, this extract supports long-term supplementation with a safety profile that underscores its quality and reliability. TurmXTRATM represents the forefront of turmeric innovation for modern wellness formulations.The global skin health and beauty-from-within market is poised to grow rapidly over the next few years. Consumer interest remains strong, with 28% of individuals expressing preference for supplements targeting skin, hair, and nail health. From a supplementation perspective, efficacy emerges as the leading purchasing driver, underscoring the importance for manufacturers to deliver scientifically backed, results-oriented products. This growing demand signals significant opportunities for brands to cater to consumers seeking effective, ingestible solutions for skin wellness from within.Elevate your glow from withinHighest curcuminoid content (60% Total Curcuminoids)Clinically substantiated at a lower dose of 250 mgHigher convenience for formulator & consumerAll-naturalglowClinically Proven Turmeric Extract for Skin Health APPLICATIONSGummiesHardcapsulesEffervescent TabletsStick PacksReady-To-DrinkMARKET INSIGHTSBeauty from withinMarket Value$1.5 billion2.3%CAGR (by 2026) Any of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.Source: NBJ Condition Specific Report 2023, 2024 CRN Consumer SurveyLearn more >New LaunchWater dispersible turmeric extract
Scan to visit websitefor more information2xImprovement in facial skin hydrationfrom Day 1529%Decrease in facial trans-epidermalwater loss by Day 15, 2x from Day 30,and 3x by Day 605xImprovement in Skin gloss16xReduction in facial blemish/spotintensity from Day 30KEY TAKEAWAYS FROM THE STUDY96 healthy adultfemales subjectsFemales aged18-40 years60 daytreatment periodSTUDY DESIGN250mg of TurmXTRATM glow, demonstrated statistically significant findingsTurmXTRA™ is a trademark of Nutriventia Pvt. Ltd. © 2025 nutriventia.com | sales@nutriventia.comAny of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.Please reach out to our Sales Team for information on product availability in your region3PK STUDIES*1CLINICAL STUDY*Refer to TurmXTRATM activeRandomized double- blind, placebo-controlled studyLICENSES & CERTIFICATIONSSource: J Cosmet Dermatol. 2025; Efficacy and safety of low-dose turmeric extract on facial skin. doi:10.1111/jocd.70462
USP compliantMultiple randomized, double-blind, placebo controlled clinicaltrials validating one-a-day dose for managing stress.Validated with a full clinical package forprolonged release.TMAlso known as *ProlanzaTM is a unique long-acting ingredient of ashwagandha root extract which complies to 10 USP Withanolides. It’s innovative release pattern ensures extended clinical benefits.STUDY 1 – PHARMACOKINETIC STUDYCompared to a leading branded Ashwagandha ingredient, ProlanzaTM showed -Superior pharmacokinetic profileProlanzaTM has a bioavailability which is nearly12 times higher as compared to the reference product.Extended AvailabilityWithanolides from ProlanzaTM are available in plasma for upto24 hours A comprehensive clinical package0 2 4 6 8 10 12 14 16 18 20 22 2400.511.522.53ReferenceTime (hrs.)Mean plasma concentration of totalwithanolidies (ng/mL)Learn more >Root-only, Sustainedrelease ashwagandhaEervescent TabletsGummiesReady-To-DrinkOrodispersiblePowderAll-day calmCapsulesAshwagandha is recognized as the fastest-growing active ingredient in the stress and adaptogen supplement segment, driven by rising consumer interest in natural stress relief and support. This growth is supported by a heightened awareness of mental health and proactive approaches to emotional well-being worldwide. MARKET INSIGHTSAPPLICATIONSStress & AdaptogenMarket Value$0.6 billion5.1%CAGR (by 2034) Source: NBJ Condition Specific Report 2023, CRN Consumer Survey Report 2024, Grandview Reserch Report 2025.*Trademarked as AshwanovaTM in some parts of the worldTMAny of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.5
STUDY 2 – A STRESS & COGNITIVE HEALTH STUDYRandomized, double-blind, placebo-controlled, 90-day clinical study on 100 healthy subjects with mild to moderate stress, supplemented with 300 mg Prolanza dailySTUDY 3 – MULTI ARM - STRESS STUDYRandomized, double-blind, placebo-controlled, 60-day clinical study in 126 healthy subjects with mild to moderate stress, receiving 150 mg, 300 mg, or placebo daily.Shefali Thanawala*, Rajat Shah, Kiran Bhupathiraju, Krishnaraju Venkata Alluri, Prabakaran Desomayanandanam, Arun BhuvenendranPosted Date: 19 February 2025doi: 10.20944/preprints202502.1076.v2Keywords: ashwagandha; happiness; sleep; stress; sustained- release; withanolides*Preprint availableHEALTH BENEFITSStress SupportSleepHealthMental WellbeingCognitive Support1Perceived stress levels 2Sleep quality3Overall mental well-being3X8.3X4X2.7X6.7X2.34XCompared to placeboProlanza™ & ashwanova™ is a trademark of Nutriventia Pvt. Ltd. © 2025 nutriventia.com | sales@nutriventia.comAny of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.Please reach out to our Sales Team for information on product availability in your regionLICENSES & CERTIFICATIONSImprovement In Sleep QualityImprovement In Memory RecallImprovement InPerceived Stress9.3X 3.5XImprovement In OverallMental Well-Being**2X 3.6X
All-night sleepMARKET INSIGHTSSleep health supplements market is a rapidly growing sector driven by increasing consumer awareness of sleep quality and the effects of modern lifestyle stressors. Melatonin dominates this segment, accounting for over 50% of the market share, supported by consumer preference and awareness. Tablets and capsules remain the leading product formats, though there is growing demand for liquid and ready-to-drink preparations due to ease of ingestion and faster absorption. Consumers prioritize efficacy, safety, and convenience in sleep supplements.Learn more >Sleep healthMarket Value$7.6 billion5.2%CAGR (by 2034) Source: NBJ Condition Specific Report 2023, CRN Consumer Survey Report 2024, Future Market Insights Sleep Supplement Report 2024.Melotime™ is a extended-release melatonin ingredient that helps mimic the body’s natural sleep pattern and supports quality sleep. The unique release profile of Melotime™ ensures a release of a significant portion in the first hour followed by continuous release of melatonin upto 6 hours for maintenance. This ensures a quick on-set and maintains good quality of sleep.Sustained-release melatonin that supports a natural 8-hour sleep cycleAny of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose,treat, cure or prevent any disease.8-hour sustained sleepSustained release profile helps to get 8 hours of sleep without side effectsSupports natural sleep patternThe unique release profile provides a quick onset and good quality restorative sleep.Sustained release patternReleases up to 50% of melatonin in the first hour with subsequent release in smaller burst for next 6 hours and tappering effect in the final hour to wake fresh.APPLICATIONSTabletsCapsulesGummies & chewsReady-To-DrinkStick packs(powder)
HEALTH BENEFITSSleepregulationAntioxidantsupportCognitivehealthImmunehealthPHARMACOKINETIC STUDYMelotime™ Melatonin IRTime (h)0180001600014000120001000080006000400020000Mean plasma concentration ofmelatonin (pg/mL)1 2 3 4 5 6 78Disturbed sleepSound sleepFastereliminationSlowereliminationScan to visit websitefor more informationLICENSES & CERTIFICATIONSExtended action through sustained release profile of Melotime™• 5X longer half life and 45% slower Tmax, prolonged availability of melatonin in plasmaSource - Thanawala S, Abiraamasundari R, Shah R. Comparative pharmacokinetics of Sustained-release versus Immediate-releasemelatonin capsules in Fasting healthy adults : a randomized, open-label, cross-over study. Pharmacokinetics. 16, 1248.Melotime™ is a trademark of Nutriventia Pvt. Ltd. © 2025 nutriventia.com | sales@nutriventia.comAny of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.Please reach out to our Sales Team for information on product availability in your region
Caffeine stimulates the nervous system leading to improved alertness, exemplified motor coordination, and recharged focus. The most significant issue with caffeine is that its effects start to diminish after a couple of hours due to quick absorption of caffeine within the body. High and/or multiple doses leads to caffeine tolerance which could lead to jitteriness, headache, and nervousness collectively known as ‘caffeine crash’. CaffXtend™ is a unique patented product that delivers natural caffeine for 12 hours, from a natural matrix using our proprietary modified-release technology.Long-acting caffeine Caffeine is the leading active ingredient in nootropic supplements, driving mental energy, focus, and alertness. NBJ data shows 79% of active consumers take supplements to boost energy and stamina, with 63% preferring natural caffeine sources in sports nutrition. This highlights caffeine’s dominance in cognitive enhancement. The global nootropic market is growing rapidly, with caffeine-based products playing a key role. Its fast, effective mental stimulation makes it the cornerstone ingredient for focus and mental performance.Source - NBJ Report, Global Market Insights Nootropic Supplement Market Report 2024.MARKET INSIGHTSHEALTH BENEFITSAPPLICATIONSAll-naturalSource of natural caffeine is fromcoffee seeds. This caffeine is embedded in a natural release controlling matrix.One-a-day doseA single dose designed for an enhanced caffeine experience, lasting up to 12 hours, offers all-day alertness and focus.Any of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat, cure, or prevent any disease.HardCapsulesEffervescent TabletsStick PacksReady-To-DrinkImproved focus andmental alertness CaffXtend™ provides 400% lesserperception of fatigue in comparison toregular natural caffeineLearn more >All-day focusGummiesNootropicMarket Value$2.3 billion7.8%CAGR (by 2034)
SUSTAINED RELEASE PROFILEClinically substantiated to reduce perception of ‘tiredness’ for an extended duration (12 hours) from a single doseThe sustained release of caffeine gives 12 hours of enhanced energy* and focus*The claims of energy are more in terms of the general meaning of the word rather than energy as referred to as ATP productionExtended action through sustainedrelease profile of CaffXtend™1.Extended Tmax – 391.57%(to reach maximum concentration)Extended half-life T½ – 22.32% longerSignificantly lower scoresfor ‘tired’ and ‘jittery’3.Lesser perception of tiredness and jittersLower scores for parametersindicative of ‘caffeine crash’4.No caffeine crash, hence saferExtended efficacy through sustainedrelease profile of CaffXtend™ from a Caff-VAS (Caffeine Research Visual Analog Scales)** significantly higher scores for ‘overall mood’, ‘relaxed’and ‘alert’2.Better mood & more alertnessCaffXtend™ is beneficial with better efficacy, as compared to repeated caffeine dosing5.Substantiated from data of human clinical trialcompared with equal dose of natural caffeinePHARMACOKINETIC STUDY#Source: Shefali Thanawala, Rajat Shah, R. Abiraamasundari, R. Senthurselvi & PrabakaranDesomayanandam (2023): Comparative Bioavailability and Benefits on Mental Functions ofNovel Extended-Release Caffeine Capsules against Immediate-Release Caffeine Capsules:An Open-Label, Randomized, Cross-over, Single-Dose Two-Way Crossover Study, Journalof Dietary Supplements, DOI: 10.1080/19390211.2022.2160529LICENSES & CERTIFICATIONSScan to visit websitefor more informationSharp declineImmediate spikeProgressiveincreaseGradualdeclineMean concentration (pg/ml)0 2 4 6 8 10 120500100015002000250030003500400045005000Time (hrs.) Caffeine IR CaXtend™ is a trademark of Nutriventia Pvt. Ltd. © 2025 nutriventia.com | sales@nutriventia.comAny of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.Please reach out to our Sales Team for information on product availability in your region
C-Fence™ is a direct compressible granularsystem of Vitamin C which is an ideal solutionfor manufacturers targeting convenient and continuous 24-hour antioxidant shield. Powered using our modified release technology, small bursts of Vitamin C are consistently released periodically, providing 24-hour antioxidant support. Unlike other sustained release products that are time-consuming to develop and manufacture, C-Fence™ just needs a single-step operation to compress granules into tablets.24-hour optimised Vitamin C direct compressible granulesLong-acting, one a day doseA single dose provides 24-hour protection making it convenient for end consumers.Natural flow C-Fence™ crafted using nature-derived excipients and patented proprietary process, offers seamless flow, enhancing manufacturing convenience.Assured consistencyEach batch of C-Fence™ undergoes pre-quality evaluation by testingtablets from a representative sample.Safety with low doseC-Fence™ averts gastric distension by gradually releasing modified Vitamin C bursts.Vitamin C is the dominant ingredient, widely recognized for its immune-boosting benefits. Consumer demand is rising for immune health support, especially among the elderly who are more vulnerable to infections. Overall, preventive health focus and growing awareness are fueling this robust market growth. Source - NBJ Supplement Business Report 2023, Grandview Reserch Immune Health RepotMARKET INSIGHTSAPPLICATIONSTablets CapletAny of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose,treat, cure, or prevent any disease.All-day immunityLearn more >Immune HealthMarket Value$26.6 billion10.72%CAGR (by 2030) C-fence™ has shown 12-hour sustainedrelease Vitamin C in-vi tro.
PHARMACOKINETIC STUDYClinically substantiated through a randomized double-blind, parallel arm, placebo-controlled clinical trial to evaluate the pharmacokinetic profile of Vitamin C from an extended action tablet from C-Fence™. Clinical trial shows that the 12-hour release profile correspondingly produces a sustained level of Vitamin C in the active state in plasma providing a 24-hour in-vivo coverage.IN VITRO DISSOLUTIONSingle dose provides a consistent release for maximum timePolymer matrixWorks by diffusion mechanism from the matrixRelease in small burstsHEALTH BENEFITSLongevitySkinhealthBrainhealthImmunehealthCardiovascularhealthLICENSES & CERTIFICATIONSExtendedTmaxCmax comparedto baseline 0 hrs85xC24 compared to baseline 0 hrs20xXShah R, Thanawala S, Abiraamasundari R. Pharmacokinetics of a Novel Sustained-Release Vitamin C Oral Tablet: A Single Dose, Randomized, Double-Blind, Placebo-Controlled Trial. J Pharmacol Pharmacother. 2022 Jul 21 ; 13 : https://doi.org/10.1177/0976500X221111669Scan to visit websitefor more informationTime (hrs.)020040060080010001200Avg. concentration of Vit. C (ng/ml)0 2 4 6 8 10 12 14 16 18 20 22 24Placebo85x20xC-Fence™ is a trademark of Nutriventia Pvt. Ltd. © 2025 nutriventia.com | sales@nutriventia.comAny of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat cure, or prevent any disease.Please reach out to our Sales Team for information on product availability in your region
In just 5 years, Nutriventia has achieved over 165 milestones,accelerating at an exponential pace and this is only the beginning of our rapid growth and expanding global impact. Peer reviewed publications Recognitions07Countries27Granted Global Patents1216Global Patents Applied36Clinical studies 22
sales@nutriventia.comendless opportunities together.Let’s explore